The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial

AIMS: Iron deficiency is common in heart failure with reduced ejection fraction (HFrEF) and negatively affects cardiac function and structure. The study the effect of ferric carboxymaltose (FCM) on cardiac reverse remodelling and contractile status in HFrEF. METHODS AND RESULTS: Symptomatic HFrEF pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Pieter, Dupont, Matthias, Dauw, Jeroen, Nijst, Petra, Herbots, Lieven, Dendale, Paul, Vandervoort, Pieter, Bruckers, Liesbeth, Tang, Wai Hong Wilson, Mullens, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691806/
https://www.ncbi.nlm.nih.gov/pubmed/34185066
http://dx.doi.org/10.1093/eurheartj/ehab411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691806/
https://www.ncbi.nlm.nih.gov/pubmed/34185066
http://dx.doi.org/10.1093/eurheartj/ehab411

Ejemplares similares